Alyeska Investment Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-367,233
| Closed | -$12.3M | – | 687 |
|
|
2025
Q1 | $12.3M | Buy |
367,233
+78,390
| +27% | +$2.63M | 0.05% | 290 |
|
|
2024
Q4 | $11.3M | Hold |
288,843
| – | – | 0.04% | 323 |
|
|
2024
Q3 | $11.4M | Sell |
288,843
-3,025
| -1% | -$119K | 0.06% | 284 |
|
|
2024
Q2 | $11.4M | Buy |
291,868
+53,025
| +22% | +$2.07M | 0.07% | 258 |
|
|
2024
Q1 | $10.3M | Buy |
+238,843
| New | +$10.3M | 0.06% | 271 |
|
|
2018
Q2 | – | Sell |
-247,057
| Closed | -$1.21M | – | 503 |
|
|
2018
Q1 | $1.21M | Sell |
247,057
-2,227
| -0.9% | -$10.9K | 0.01% | 350 |
|
|
2017
Q4 | $704K | Sell |
249,284
-200,000
| -45% | -$565K | 0.01% | 365 |
|
|
2017
Q3 | $1.33M | Buy |
449,284
+8,024
| +2% | +$23.7K | 0.01% | 378 |
|
|
2017
Q2 | $1.39M | Buy |
441,260
+1,366
| +0.3% | +$4.3K | 0.01% | 355 |
|
|
2017
Q1 | $1.76M | Buy |
+439,894
| New | +$1.76M | 0.01% | 391 |
|